Medibeacon
MediBeacon Inc, based in Saint Louis, MO, is a medical technology company specializing in the development of fluorescent tracer agents and transdermal measurement. Their advanced technology allows for non-invasive detection of changes in patient levels of fluorescent GFR tracer agents, providing real-time insights into kidney function. With a focus on improving patient care, MediBeacon's innovative solutions have the potential to revolutionize the monitoring and measurement of vital organ systems.
Through their preclinical and clinical studies, MediBeacon is advancing the use of fluorescence to measure and monitor disease progression. Their patented composition of matter, algorithm, and method patents serve as a foundation for continued innovation in the field. With a commitment to quality and a team of industry leaders, MediBeacon aims to provide clinically practical solutions that can reduce healthcare costs and improve the standard of care. Their technology is trusted by leading academic centers, research institutes, contract research organizations, and pharmaceutical companies worldwide.
Generated from the website

